BlueWillow Biologics to Present Significant Progress on Its Novel Intranasal Vaccine Technology at World Vaccine Congress Europe
Presentation will demonstrate safety and immunogenicity, provide an update on NIH-funded bird flu trial, and highlight the technology’s potential in pandemic preparedness.
https://bluewillow.com/wp-content/uploads/2023/02/bw-logo-enfold.png00Tedhttps://bluewillow.com/wp-content/uploads/2023/02/bw-logo-enfold.pngTed2024-10-28 12:38:012024-10-28 12:41:21BlueWillow Biologics to Present Significant Progress on Its Novel Intranasal Vaccine Technology at World Vaccine Congress Europe
